A study of Atezolizumab in combo w/ chemo in pts w/ NSCLC

- Progression Free Survival (PFS) as determined by the Investigator using Response Evaluation Criteria in Solid Tumors - Objective Response as determined by the Investigator using RECIST v1.1 - Overall Survival (OS) - Duration of response as determined by the Investigator using RECIST v1.1 - PFS as determined by the Independent Review Facility using RECIST v1.1

June 03, 2016